Literature DB >> 19221416

Translation initiation of the human tau mRNA through an internal ribosomal entry site.

Bethany L Veo1, Les A Krushel.   

Abstract

Neurofibrillary tangles are a pathological phenotype in Alzheimer's disease (AD) and are caused by the hyperphosphorylation of the microtubule associated protein tau. In mouse models of AD, decreasing tau protein expression limits the severity of symptoms and inhibits progression of AD. We now report that the 5' leader in the human tau mRNA contains an internal ribosomal entry site (IRES) and that IRES-dependent translation plays a role in the synthesis of tau protein. Consequently, targeting the tau IRES provides a novel target for regulating tau expression in AD and other tauopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221416     DOI: 10.3233/JAD-2009-0978

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.

Authors:  Bethany L Veo; Leslie A Krushel
Journal:  RNA Biol       Date:  2012-09-20       Impact factor: 4.652

2.  eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease.

Authors:  Andrew Bottley; Nicola M Phillips; Thomas E Webb; Anne E Willis; Keith A Spriggs
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

3.  Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein.

Authors:  Yun-Chieh Tasi; Ting-Yu Chin; Ying-Ju Chen; Chun-Chih Huang; Shou-Lun Lee; Tzong-Yuan Wu
Journal:  Int J Mol Sci       Date:  2015-04-20       Impact factor: 5.923

Review 4.  Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Authors:  Paulo J da Costa; Malika Hamdane; Luc Buée; Franck Martin
Journal:  Biomedicines       Date:  2022-01-23

5.  Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans.

Authors:  Maria L Maccecchini; Mee Young Chang; Catherine Pan; Varghese John; Henrik Zetterberg; Nigel H Greig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-11       Impact factor: 10.154

6.  Cell type specificity and structural determinants of IRES activity from the 5' leaders of different HIV-1 transcripts.

Authors:  Terra-Dawn M Plank; James T Whitehurst; Jeffrey S Kieft
Journal:  Nucleic Acids Res       Date:  2013-05-09       Impact factor: 16.971

Review 7.  The Role of RNA Binding Proteins for Local mRNA Translation: Implications in Neurological Disorders.

Authors:  Maximilian Paul Thelen; Min Jeong Kye
Journal:  Front Mol Biosci       Date:  2020-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.